|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02315 BIOCYTOGEN-B
Nominal 
57.250 -1.200 (-2.053%) Non-current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Investment Properties | -- | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | -- | -- | 1,349,489 | 1,450,828 | 1,599,079 | 1,390,945 |
| Land & other Lease Assets | -- | -- | 0 | 0 | 0 | 0 |
| Intangible Assets | -- | -- | 20,665 | 28,130 | 30,652 | 6,055 |
| Interests in Asso. & JCEs | -- | -- | 159,038 | 188,375 | 197,944 | 9,685 |
| Other Non-current Assets | -- | -- | 69,587 | 59,025 | 52,861 | 21,860 |
| -- | -- | 1,598,779 | 1,726,358 | 1,880,536 | 1,428,545 | |
Current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Inventories | -- | -- | 3,890 | 7,416 | 18,604 | 15,140 | |
| Trade Receivables | -- | -- | 229,608 | 142,384 | 107,682 | 103,089 | |
| Cash & Bank Balances | -- | -- | 384,458 | 399,607 | 610,882 | 466,445 | |
| Other Current Assets | -- | -- | 198,579 | 173,643 | 182,128 | 289,564 | |
| Assets Held for Sale | -- | -- | 0 | 0 | 0 | 0 | |
| -- | -- | 816,535 | 723,050 | 919,296 | 874,238 | ||
Current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||
| Trade Payables | -- | -- | 115,479 | 175,234 | 146,190 | 102,441 | ||
| S-T Debt & Leases | -- | -- | 225,995 | 203,199 | 171,603 | 26,897 | ||
| Other Current Liabilities | -- | -- | 193,439 | 199,183 | 288,253 | 317,221 | ||
| Liab asso w/ Assets Held for Sale | -- | -- | 0 | 0 | 0 | 0 | ||
| -- | -- | 534,913 | 577,616 | 606,046 | 446,559 | |||
| Net Current Assets | -- | -- | 281,622 | 145,434 | 313,250 | 427,679 | ||
| Total Assets Less Current Liabilities | -- | -- | 1,880,401 | 1,871,792 | 2,193,786 | 1,856,224 | ||
Non-current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||||
| L-T Debt & Leases | -- | -- | 344,282 | 340,910 | 243,677 | 62,902 | |||
| Other Non-current Liabilities | -- | -- | 697,518 | 740,446 | 799,293 | 541,351 | |||
| -- | -- | 1,041,800 | 1,081,356 | 1,042,970 | 604,253 | ||||
Capital and Reserves
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||||
| Share Capital | -- | -- | 399,398 | 399,398 | 399,398 | 374,930 | ||||
| Reserves | -- | -- | 434,658 | 386,488 | 746,867 | 872,278 | ||||
| Others | -- | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | -- | -- | 834,056 | 785,886 | 1,146,265 | 1,247,208 | ||||
| Non-controlling Interests | -- | -- | 4,545 | 4,550 | 4,551 | 4,763 | ||||
| Others | -- | -- | 0 | 0 | 0 | 0 | ||||
| -- | -- | 838,601 | 790,436 | 1,150,816 | 1,251,971 | |||||
Commitments and Contingent Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Commitments | -- | -- | 0 | 12,458 | 8,838 | 52,575 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 30/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 173,199 |
| %Change | 416.365% |
| EPS / (LPS) | RMB 0.430 |
| NBV Per Share (¥) | RMB -- |